All Business articles – Page 12
-
Business
AstraZeneca to buy rare disease drugmaker Alexion in $39bn deal
Transaction would be the largest in AstraZeneca’s history
-
Business
Pfizer–BioNTech vaccine gains emergency approvals in US, Canada and beyond
UK begins vaccinating vulnerable populations after early authorisation
-
Business
Fatal explosion at US chemical plant
Blast at Optima facility killed one and injured three others
-
Business
Oxford Biotrans makes its grapefruit compound out of oranges
Using their patented enzymes, Oxford Biotrans’ mission is to create new routes to useful chemicals – starting with their natural-grade food and fragrance products
-
Business
4 dead in UK sewage treatment works explosion
One person injured as biosolids silo explodes at Avonmouth
-
Business
UK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
Business
Brexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
Business
Oxford–AstraZeneca vaccine joins others with promising interim data
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease
-
Business
Taking plastic out of performance paper coatings
SGMA’s silicate sol-gel is a sustainable alternative for packaging such as coffee cups
-
Business
Regulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
Business
Moderna and Pfizer’s Covid-19 vaccines add more encouraging data
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
-
Business
Early indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
Business
Innovation is a fragile transition state
Brexit and Covid-19 will likely stifle interactions, but could also stimulate new ones
-
Business
Stepping towards diversity in industry
Companies are re-affirming their commitment to inclusivity, even as the US government obstructs education efforts
-
Business
Stretching liquid crystals to the limit with LC AuxeTec
The unintuitive properties of LC AuxeTec’s materials mean they thicken when stretched, and could be exploited in body armour and skyscraper windows
-
Business
EU commits to overhaul of chemicals legislation
The Chemicals Strategy for Sustainability promises the biggest reform since Reach
-
Business
Covid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
Business
Arkema acquitted over hurricane fire emissions
US Judge rules there is insufficient evidence to bring criminal charges relating to peroxide fire caused by flooding in 2017
-
Business
Covid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
-
Business
Protein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness